When the GLP-1 receptor is activated across these systems, several metabolic processes occur: Improved insulin sensitivity Better glucose uptake by cells Reduced excessive glucagon production Enhanced satiety signaling to the brain More stable energy levels after meals Together, these changes create a metabolic environment that supports efficient energy usage rather than excess energy storage
Three studies did not show weight gain after treatment-induced weight loss, although each used different strategies or reported outcomes differently
Cardiometabolic Research Beyond weight reduction, retatrutide's glucagon receptor component has attracted research interest for its cardiovascular effects
Drugs 78(11):11131132 dAquino AI, Maikawa CL, Nguyen LT, Lu K, Hall IA, Jons CK, et al (2023) Use of a biomimetic hydrogel depot technology for sustained delivery of GLP-1 receptor agonists reduces burden of diabetes management
Anthem (Indiana, converted) acquired Trigon (Virginia, converted) in 2002
